Contract 36F79726D0099
Roche Diabetes Care Inc · Department Of Veterans Affairs · March 14, 2026
Roche Diabetes Care Inc was awarded a federal contract by Department Of Veterans Affairs on March 14, 2026 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 19, 2026.
Contract details
- PIID
- 36F79726D0099
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- First action
- March 14, 2026
- Latest action
- May 19, 2026
Description
65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD
Modification timeline
-
May 19, 2026Mod P00002$0
-
March 14, 2026Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Biomerieux Inc | Department Of Veterans Affairs | July 2, 2026 | $845.5K |
| Abbott Laboratories Inc. | Department Of Veterans Affairs | July 2, 2026 | $11.0K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $1.2K |
| Tosoh Bioscience, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Abbott Molecular Inc. | Department Of Veterans Affairs | July 1, 2026 | $729.8K |
| Cepheid | Department Of Veterans Affairs | July 1, 2026 | $305.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79726D0099?
Contract 36F79726D0099 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Veterans Affairs on March 14, 2026 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36F79726D0099?
Roche Diabetes Care Inc won contract 36F79726D0099 from Department Of Veterans Affairs.
How much is contract 36F79726D0099 worth?
Contract 36F79726D0099 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.